Albert David

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
761.05
7.45 (0.99%)
BSENSE

Nov 20

BSE+NSE Vol: 4.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 876497,
    "name": "Albert David",
    "stock_name": "Albert David",
    "full_name": "Albert David Ltd",
    "name_url": "stocks-analysis/albert-david",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "761.05",
    "chg": 7.45,
    "chgp": "0.99%",
    "dir": 1,
    "prev_price": "753.60",
    "mcapval": "439.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524075,
    "symbol": "ALBERTDAVD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE155C01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.25 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/albert-david-876497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Albert David Ltd Valuation Shifts Signal Attractive Entry Point Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/albert-david-ltd-valuation-shifts-signal-attractive-entry-point-amid-sector-challenges-4264615",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlbertDavidLtd_valuationdot_4264615.png",
        "date": "2026-11-17 08:01:48",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, prompting an upgrade in its investment grade from Hold to Buy. With a current price of ₹778.90 and a price-to-earnings (P/E) ratio of 15.46, the stock now presents an attractive valuation compared to its historical averages and peer group, signalling a potential opportunity for investors seeking value in a competitive industry."
      },
      {
        "title": "Albert David Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-is-rated-hold-by-marketsmojo-4257799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlbertDavidLtd_mojoScore_4257799.png",
        "date": "2026-11-11 10:10:52",
        "description": "Albert David Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 October 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 11 November 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Albert David Ltd Valuation Shifts to Attractive Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/albert-david-ltd-valuation-shifts-to-attractive-amid-sector-challenges-4251292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlbertDavidLtd_valuationdot_4251292.png",
        "date": "2026-11-05 08:02:26",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed returns and sector-wide valuation pressures, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks."
      },
      {
        "title": "Albert David Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-is-rated-hold-by-marketsmojo-4244517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlbertDavidLtd_mojoScore_4244517.png",
        "date": "2026-10-30 10:10:48",
        "description": "Albert David Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Albert David Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-is-rated-hold-by-marketsmojo-4230099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlbertDavidLtd_mojoScore_4230099.png",
        "date": "2026-10-19 10:10:41",
        "description": "Albert David Ltd is rated Hold by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Albert David Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-downgraded-to-hold-amid-mixed-technical-and-financial-signals-4218283",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlbertDavidLtd_mojoScore_4218283.png",
        "date": "2026-10-08 08:16:10",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 7 October 2026. This revision reflects a nuanced assessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite recent strong quarterly earnings and a net-debt-free balance sheet."
      },
      {
        "title": "Albert David Ltd Upgraded to Buy on Strong Financial and Technical Improvements",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-upgraded-to-buy-on-strong-financial-and-technical-improvements-4207883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlbertDavidLtd_mojoScore_4207883.png",
        "date": "2026-09-29 08:40:28",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 28 Sep 2026. This upgrade reflects significant improvements across technical indicators, financial performance, valuation metrics, and overall quality scores, positioning the stock favourably against its peers and broader market benchmarks."
      },
      {
        "title": "Albert David Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4203077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlbertDavidLtd_mojoScore_4203077.png",
        "date": "2026-09-24 08:23:06",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 23 September 2026. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, despite the company’s strong recent profit growth and market-beating returns."
      },
      {
        "title": "Albert David Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/albert-david-ltd-downgraded-to-hold-amid-mixed-technical-and-financial-signals-4185998",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlbertDavidLtd_mojoScore_4185998.png",
        "date": "2026-09-08 08:51:46",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 7 September 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust quarterly earnings and a net-debt-free balance sheet, evolving technical indicators and valuation premiums have tempered enthusiasm among analysts."
      }
    ],
    "total": 36,
    "sid": "876497",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/albert-david-876497"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Nov-2026",
      "details": "Newspaper publication dated 18th November 2026 in Financial Express(All India Editions) and Aajkal (Bengali Newspaper) about 5th Reminder for Special Window for Re-lodgment of physical Transfer",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2026",
      "details": "Newspaper Publication-Regarding Extract of Unaudited Financial Results for the quarter and half year ended 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026",
      "datetime": "12-Nov-2026",
      "details": "Unaudited Financial Results for the quarter and half year ended 30th September 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Albert David Ltd has declared <strong>50%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Nov-2026 | Source : BSE

Newspaper publication dated 18th November 2026 in Financial Express(All India Editions) and Aajkal (Bengali Newspaper) about 5th Reminder for Special Window for Re-lodgment of physical Transfer

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2026 | Source : BSE

Newspaper Publication-Regarding Extract of Unaudited Financial Results for the quarter and half year ended 30th September 2026

Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026

12-Nov-2026 | Source : BSE

Unaudited Financial Results for the quarter and half year ended 30th September 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Albert David Ltd has declared 50% dividend, ex-date: 30 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available